Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Net Cash Flow (2016 - 2025)

Prestige Consumer Healthcare has reported Net Cash Flow over the past 16 years, most recently at -$57.0 million for Q4 2025.

  • Quarterly results put Net Cash Flow at -$57.0 million for Q4 2025, down 4142.91% from a year ago — trailing twelve months through Dec 2025 was $10.3 million (up 189.88% YoY), and the annual figure for FY2025 was $52.0 million, up 526.13%.
  • Net Cash Flow for Q4 2025 was -$57.0 million at Prestige Consumer Healthcare, down from -$20.4 million in the prior quarter.
  • Over the last five years, Net Cash Flow for PBH hit a ceiling of $131.6 million in Q2 2021 and a floor of -$119.9 million in Q3 2021.
  • Median Net Cash Flow over the past 5 years was $1.8 million (2023), compared with a mean of $89700.0.
  • Biggest five-year swings in Net Cash Flow: surged 439.6% in 2021 and later plummeted 4142.91% in 2025.
  • Prestige Consumer Healthcare's Net Cash Flow stood at -$21.6 million in 2021, then soared by 299.9% to $43.1 million in 2022, then plummeted by 95.05% to $2.1 million in 2023, then crashed by 33.9% to $1.4 million in 2024, then plummeted by 4142.91% to -$57.0 million in 2025.
  • The last three reported values for Net Cash Flow were -$57.0 million (Q4 2025), -$20.4 million (Q3 2025), and $40.8 million (Q2 2025) per Business Quant data.